CIK: 1220050 - Address: C/o Threshold Pharmaceuticals, Inc., 170 Harbor Way, Suite 300, South San Francisco, CA 94080
22 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y
2/5/09 16:02
2/3/09
OSIPOsi Pharmaceuticals IncDEHealthDiagnIn Vitro & In Vivo DiagnosticSimon Robert LNYOEVP,PharM.d7321.55031134
2/5/09 16:02
2/3/09
OSIPOsi Pharmaceuticals IncDEHealthDiagnIn Vitro & In Vivo DiagnosticSimon Robert LNYOEVP,PharS.d-14041.250-3-934
1/7/09 11:45
1/6/09
OSIPOsi Pharmaceuticals IncDEHealthDiagnIn Vitro & In Vivo DiagnosticSimon Robert LNYOEVP,PharM.d121.5500034
1/7/09 11:45
1/6/09
OSIPOsi Pharmaceuticals IncDEHealthDiagnIn Vitro & In Vivo DiagnosticSimon Robert LNYOEVP,PharS.d-240.0000034
11/12/08 10:17
11/7/08
OSIPOsi Pharmaceuticals IncDEHealthDiagnIn Vitro & In Vivo DiagnosticSimon Robert LNYOEVP,PharM.d2521.5501525D
11/12/08 10:17
11/7/08
OSIPOsi Pharmaceuticals IncDEHealthDiagnIn Vitro & In Vivo DiagnosticSimon Robert LNYOEVP,PharS.d-4841.590-1-425D
10/2/08 15:00
10/1/08
OSIPOsi Pharmaceuticals IncDEHealthDiagnIn Vitro & In Vivo DiagnosticSimon Robert LNYOEVP,PharM.d2521.5501430D
10/2/08 15:00
10/1/08
OSIPOsi Pharmaceuticals IncDEHealthDiagnIn Vitro & In Vivo DiagnosticSimon Robert LNYOEVP,PharS.d-5648.700-1-430D
9/4/08 14:51
9/2/08
OSIPOsi Pharmaceuticals IncDEHealthDiagnIn Vitro & In Vivo DiagnosticSimon Robert LNYOEVP,PharM.d2521.5501430D
9/4/08 14:51
9/2/08
OSIPOsi Pharmaceuticals IncDEHealthDiagnIn Vitro & In Vivo DiagnosticSimon Robert LNYOEVP,PharS.d-5850.420-1-430D
8/5/08 13:10
8/1/08
OSIPOsi Pharmaceuticals IncDEHealthDiagnIn Vitro & In Vivo DiagnosticSimon Robert LNYOEVP,PharM.d2521.5501430D
8/5/08 13:10
8/1/08
OSIPOsi Pharmaceuticals IncDEHealthDiagnIn Vitro & In Vivo DiagnosticSimon Robert LNYOEVP,PharS.d-6052.270-1-430D
7/3/08 15:52
7/1/08
OSIPOsi Pharmaceuticals IncDEHealthDiagnIn Vitro & In Vivo DiagnosticSimon Robert LNYOEVP,PharM.d2521.5501525D
7/3/08 15:52
7/1/08
OSIPOsi Pharmaceuticals IncDEHealthDiagnIn Vitro & In Vivo DiagnosticSimon Robert LNYOEVP,PharS.d-4841.320-1-425D
6/9/08 14:07
6/5/08
OSIPOsi Pharmaceuticals IncDEHealthDiagnIn Vitro & In Vivo DiagnosticSimon Robert LNYOEVP,PharM.d4921.50021025D
6/9/08 14:07
6/5/08
OSIPOsi Pharmaceuticals IncDEHealthDiagnIn Vitro & In Vivo DiagnosticSimon Robert LNYOEVP,PharS.d-9240.000-2-825D
1/5/05 17:13
1/3/05
OSIPOsi Pharmaceuticals IncDEHealthDiagnIn Vitro & In Vivo DiagnosticSimon Robert LNYOVP,GlobaM.d14328.59055D
1/5/05 17:13
1/3/05
OSIPOsi Pharmaceuticals IncDEHealthDiagnIn Vitro & In Vivo DiagnosticSimon Robert LNYOVP,GlobaS.d-34973.490-5-515D
12/21/04 15:13
12/17/04
OSIPOsi Pharmaceuticals IncDEHealthDiagnIn Vitro & In Vivo DiagnosticSimon Robert LNYOVP,GlobaM.d20345.01054D
12/21/04 15:13
12/17/04
OSIPOsi Pharmaceuticals IncDEHealthDiagnIn Vitro & In Vivo DiagnosticSimon Robert LNYOVP,GlobaS.d-25370.000-4-464D
10/18/04 14:59
10/15/04
OSIPOsi Pharmaceuticals IncDEHealthDiagnIn Vitro & In Vivo DiagnosticSimon Robert LNYOVP,GlobaM.d7521.55043D
10/18/04 14:59
10/15/04
OSIPOsi Pharmaceuticals IncDEHealthDiagnIn Vitro & In Vivo DiagnosticSimon Robert LNYOVP,GlobaS.d-22363.620-4-573D

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact